Rules and Regulations

Latest Issue of OR Manager
April 2024
Home Regulations/Legal > Rules and Regulations

Getting ready for the OAS CAHPS Survey 2025 requirement

Editor's Note Starting in 2025, Medicare-certified ambulatory surgery centers (ASCs) will be required to participate in the Outpatient and Ambulatory Surgery Consumer Assessment of Healthcare Providers and Systems (OAS CAHPS) Survey to comply with the ASC Quality Reporting Program, reports the Ambulatory Surgery Center Association (ASCA) and Outpatient Surgery Magazine…

Read More

By: Tarsilla Moura
April 24, 2024
Share

FDA approves imaging drug for detecting cancer after lumpectomy

Editor's Note The US Food and Drug Administration (FDA) approved Lumisight (pegulicianine), a fluorescent imaging drug used to detect cancerous tissue during lumpectomy, on April 17. Administered intravenously prior to surgery, Lumisight is designed for use with the Lumicell Direct Visualization System (DVS) or another imaging device that is FDA-approved…

Read More

By: Matt Danford
April 22, 2024
Share

Penn Medicine anesthesia, waste initiatives boost OR sustainability

Editor's Note Penn Medicine has made significant strides in reducing the environmental footprint of the OR through department- and team-level initiatives, according to a March 29 report in Penn Medicine news. Driven by CIRCE: Medicine, a faculty group consisting of providers from Penn Medicine and Children’s Hospital of Philadelphia, examples…

Read More

By: Matt Danford
April 22, 2024
Share

FDA: Surgical mesh mini-slings comparable to mid-urethral slings for stress urinary incontinence

Editor's Note Mini-slings for stress urinary incontinence (SUI) are similarly effective to mid-urethral slings over a 36-month timeframe, according to an April 11 announcement from the US Food & Drug Administration (FDA). FDA reached this conclusion after an in-depth, systematic literature review of post-market surveillance (“522”) studies required last year…

Read More

By: Matt Danford
April 15, 2024
Share

Sponsored Message

Federal regulations require written consent for pelvic exams at hospitals, medical schools

Editor's Note New federal guidelines require obtaining written informed consent before conducting pelvic and other sensitive medical examinations, according to an April 2 Associated Press report. The new guidance from the US Department of Health and Human Services focuses specifically on medical students, nurse practitioners, and physician assistants performing breast,…

Read More

By: Matt Danford
April 15, 2024
Share

Annual CMS rules support underserved, under-resourced communities, promote value-based care

Editor's Note Addressing social determinants of health (SDOHs), strengthening emergency preparedness, and improving maternal heath are among the top priorities of the fiscal year (FY) 2025 Inpatient Prospective Payment System (IPPS) and Long-Term Care Hospital Prospective Payment System (LTCH PPS) rules released April 10. These and other efforts aim to…

Read More

By: Matt Danford
April 12, 2024
Share

Sponsored Message

Medical error initiative from Joint Commission affiliate NQF targets preventable harm, “never events”

Editor's Note Designed to address high rates of preventable medical errors, a new initiative from The National Quality Form (NQF), an affiliate of The Joint Commission, will modernize criteria for what constitutes a Serious Reportable Event (SRE) and align standards for reporting such events across different accountability systems. Dubbed “Focus…

Read More

By: Matt Danford
April 11, 2024
Share

EPA rule to limit dangerous emissions from medical sterilization plants

USA Today logo

Editor's Note The Environmental Protection Agency (EPA) has finalized a rule to reduce chloroprene and ethylene oxide emissions that will impact over 200 chemical plants across the nation, including medical sterilization plants, according to an April 10 report from USA Today. Under the new rule, the EPA will cut more…

Read More

By: Brita Belli
April 11, 2024
Share

FDA approves new antibiotic for staph, other infections

Editor's Note The US Food and Drug administration approved Zevtera for treating Staphylococcus aureus bacteremia (SAB) bloodstream infections, which are often acquired in healthcare settings. In the April 3 announcement, the agency notes the new antibiotic Zevtera (ceftobiprole medocaril sodium for injection) is effective for SAB-infected patients with right-sided infective…

Read More

By: Matt Danford
April 4, 2024
Share

Private payers profit by delaying medical claims

Editor's Note Private payers initially deny reimbursement on 15% of claims, only to later approve more than half of those initial denials, according to a national survey of healthcare institutions published March 21 by Premiere, Inc. Additionally, the denied claims on average tend to be more prevalent for higher-cost treatments…

Read More

By: Matt Danford
April 4, 2024
Share

Join our community

Learn More
Video Spotlight
Live chat by BoldChat